Klotho Neurosciences, Inc. — Investor Relations & Filings
Filings indexed
209
across all filing types
Latest filing
2026-05-26
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
KLTO
Klotho Neurosciences, Inc. is a biopharmaceutical company focused on the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders. The company develops treatments for conditions with high unmet medical needs, including amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. Its core approach involves pioneering gene and cell therapies that utilize DNA and RNA as therapeutics. A key area of its research is centered on genomic therapies targeting the alpha-Klotho gene, a known regulator of aging. The company's portfolio consists of proprietary cell and gene therapy programs designed to offer transformative outcomes for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PROXY STATEMENT | 2026-05-26 | English | |
| CURRENT REPORT | 2026-05-21 | English | |
| QUARTERLY REPORT | 2026-05-20 | English | |
| AMENDMENT NO. 1 TO FORM 8-K | 2026-05-19 | English | |
| CURRENT REPORT | 2026-05-14 | English | |
| 8-K - Greenland Mines Ltd (0001907223) (Filer) | 2026-04-22 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47072221 | PROXY STATEMENT | 2026-05-26 | English | ||
| 46735799 | CURRENT REPORT | 2026-05-21 | English | ||
| 46692816 | QUARTERLY REPORT | 2026-05-20 | English | ||
| 46558774 | AMENDMENT NO. 1 TO FORM 8-K | 2026-05-19 | English | ||
| 46085874 | CURRENT REPORT | 2026-05-14 | English | ||
| 35327712 | 8-K - Greenland Mines Ltd (0001907223) (Filer) | 2026-04-22 | English | ||
| 33015998 | 8-K - Greenland Mines Ltd (0001907223) (Filer) | 2026-03-23 | English | ||
| 32900454 | 8-K - KLOTHO NEUROSCIENCES, INC. (0001907223) (Filer) | 2026-03-04 | English | ||
| 32900453 | 8-K - KLOTHO NEUROSCIENCES, INC. (0001907223) (Filer) | 2026-03-02 | English | ||
| 32900455 | 8-K - KLOTHO NEUROSCIENCES, INC. (0001907223) (Filer) | 2026-02-24 | English | ||
| 32202850 | 8-K Filing | 2026-02-17 | English | ||
| 13574277 | PROXY STATEMENT | 2026-01-26 | English | ||
| 13574278 | PROXY STATEMENT | 2026-01-23 | English | ||
| 13574279 | PROXY STATEMENT | 2026-01-12 | English | ||
|
2025
1 filing
| |||||
| 13574280 | Regulatory Filings 2025 | 2025-12-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
Klotho Neurosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34788/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34788 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34788 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34788 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34788}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Klotho Neurosciences, Inc. (id: 34788)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.